Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin

Autor:	Stephen A. Farkas, Steven Jon Berman, Ronald W. Geckler, Barry Sieger
Rok vydání:	1997
Předmět:	medicine.medical_specialty Respiratory tract infections business.industry Respiratory disease Ceftazidime Critical Care and Intensive Care Medicine medicine.disease Meropenem Surgery Tolerability Internal medicine Multicenter trial medicine Tobramycin business medicine.drug Antibacterial agent
Zdroj:	Critical Care Medicine. 25:1663-1670
ISSN:	0090-3493
DOI:	10.1097/00003246-199710000-00015
Popis:	Objective To evaluate the efficacy and tolerability of intravenous empiric treatment with meropenem compared with ceftazidimetobramycin in patients with hospital-acquired lower respiratory tract infections.Design Prospective, nonblind, randomized trial.Setting Multicenter trial conducted at 22 cente
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::33e4485df58875b5e0b5104bdb6c05c6 https://doi.org/10.1097/00003246-199710000-00015 Zobrazit plný text záznamu